Paper42860281PubMed
Clinical evaluation and treatment of obesity in women across selected life stages: a narrative review.
Lee Y and 1 other. Womens Health Nurs, 2026.
Cite this record
ConductScience Library. Clinical evaluation and treatment of obesity in women across selected life stages: a narrative review. Papers, record 42860281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42860281
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical evaluation and treatment of obesity in women across selected life stages: a narrative review.
- Journal
- Womens Health Nurs
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-14
Source PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Obesity | Major topic |
| Humans | |
| Female | |
| Polycystic Ovary Syndrome | |
| Menopause | |
| Body Mass Index |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28538730 | Blocking FSH induces thermogenic adipose tissue and reduces body fat. | Nature | 2017 | https://conductscience.org/library/papers/28538730 | PubMed |
| 2 | 32753461 | Obesity in adults: a clinical practice guideline. | CMAJ | 2020 | https://conductscience.org/library/papers/32753461 | PubMed |
| 3 | 38536037 | Effects of follicle-stimulating hormone on energy balance and tissue metabolic health after loss of ovarian function. | Am J Physiol Endocrinol Metab | 2024 | https://conductscience.org/library/papers/38536037 | PubMed |
| 4 | 30785613 | Addressing Medicine's Bias Against Patients Who Are Overweight. | JAMA | 2019 | https://conductscience.org/library/papers/30785613 | PubMed |
| 5 | 37580314 | Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. | J Clin Endocrinol Metab | 2023 | https://conductscience.org/library/papers/37580314 | PubMed |
| 6 | 22029981 | Long-term persistence of hormonal adaptations to weight loss. | N Engl J Med | 2011 | https://conductscience.org/library/papers/22029981 | PubMed |
| 7 | 27188659 | Menopause. | Nat Rev Dis Primers | 2015 | https://conductscience.org/library/papers/27188659 | PubMed |
| 8 | 28617414 | Obesity. | Nat Rev Dis Primers | 2017 | https://conductscience.org/library/papers/28617414 | PubMed |
| 9 | 35658024 | Tirzepatide Once Weekly for the Treatment of Obesity. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35658024 | PubMed |
| 10 | 25752756 | Impact of weight bias and stigma on quality of care and outcomes for patients with obesity. | Obes Rev | 2015 | https://conductscience.org/library/papers/25752756 | PubMed |
| 11 | 22618581 | Shared decision making: a model for clinical practice. | J Gen Intern Med | 2012 | https://conductscience.org/library/papers/22618581 | PubMed |
| 12 | 19188927 | A proposed clinical staging system for obesity. | Int J Obes (Lond) | 2009 | https://conductscience.org/library/papers/19188927 | PubMed |
| 13 | 34156162 | Selection of antiobesity medications based on phenotypes enhances weight loss: A pragmatic trial in an obesity clinic. | Obesity (Silver Spring) | 2021 | https://conductscience.org/library/papers/34156162 | PubMed |
| 14 | 33567185 | Once-Weekly Semaglutide in Adults with Overweight or Obesity. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33567185 | PubMed |
| 15 | 11234459 | Obesity: preventing and managing the global epidemic. Report of a WHO consultation. | World Health Organ Tech Rep Ser | 2000 | https://conductscience.org/library/papers/11234459 | PubMed |
| 16 | 38446869 | Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use. | Menopause | 2024 | https://conductscience.org/library/papers/38446869 | PubMed |
| 17 | 35797481 | The 2022 hormone therapy position statement of The North American Menopause Society. | Menopause | 2022 | https://conductscience.org/library/papers/35797481 | PubMed |
| 18 | 39824205 | Definition and diagnostic criteria of clinical obesity. | Lancet Diabetes Endocrinol | 2025 | https://conductscience.org/library/papers/39824205 | PubMed |
| 19 | 36945077 | Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity. | J Obes Metab Syndr | 2023 | https://conductscience.org/library/papers/36945077 | PubMed |
| 20 | 33759389 | Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic. | Obesity (Silver Spring) | 2021 | https://conductscience.org/library/papers/33759389 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42860281
GET https://conductscience.org/api/papers/v1/42860281/references?page=2